Amino Innovations Forms Strategic Research Partnership with University of Alberta Scientists to Advance Peptide Innovation

(TheNewswire)

Vancouver, British Columbia – TheNewswire - October 23, 2025 – Pangea Natural FoodsInc. (CSE: PNGA) (OTC: PNGAF) (“ Pangea ” or the“ Company ”), is pleased to announce that its wholly ownedsubsidiary, Amino Innovations, has formed a strategic scientificcollaboration partnership with two world-renowned pharmaceuticalscientists, Dr. Neal Davies and Dr. Raimar Loebenberg, to acceleratethe research, validation, and development of advanced non-injectablepeptide delivery systems for consumer wellness applications.

Dr. Davies and Dr. Loebenberg, both senior professorsin the Faculty of Pharmacy and Pharmaceutical Sciences at theUniversity of Alberta, will provide formulation and validationexpertise through a Research Services Agreement that leverages accessto the University’s Drug Development and Innovation Centre (DDIC)and its state-of-the-art facilities, personnel, and pharmaceuticaltesting platforms.

Scope of Collaboration

Through this collaboration, Amino Innovations aims toestablish a new benchmark for precision peptide delivery across oral,dermal, and topical formulations. The team will conduct in vitro, exvivo, and in silico studies to quantify absorption, bioavailability,and stability of select peptides, including BPC-157, GHK-Cu, and KPV,using natural and safe permeation enhancers such as Tremellafuciformis (Snow Mushroom) and DMSO to improve efficacy and productperformance.

Key areas of research include:

• Pharmacokinetic (PK) and pharmacodynamic (PD)modeling to optimize formulation parameters anddelivery profiles

• Permeation and dissolution testing using skin andtissue-based membrane models

• Formulation refinement using natural excipients andbotanical actives for enhanced bioavailability

• Stability and analytical testing to confirm productintegrity and longevity

The data generated from this research will strengthenAmino Innovations’ growing intellectual property portfolio, enhanceregulatory credibility, and accelerate new product development acrossthe nutraceutical and cosmeceutical markets.

Dr. Neal Davies and Dr. Raimar Loebenberg stated, “Weare thrilled to work with Amino Innovations, a company that is focusedon evidence-based, non-injectable natural peptide innovation. Ourexpertise in biopharmaceutics, formulation science, and translationalresearch will help bring forward validated peptide technologies withmeasurable impact in wellness and health science.”

Mr. Justin Kirkland, CSO and Co-Founder of AminoInnovations, commented, “This partnership gives us access to leadingresearch expertise and infrastructure. By generating pharmacokineticand permeability data on key peptide actives, we are creating a levelof scientific transparency within the wellness industry.”

Mr. Pratap Sandhu, CEO of Pangea, added, “We areexcited to support Amino Innovations as it continues to lead inscience driven wellness innovation. This partnership reinforces ourcommitment to developing credible, research backed products thatstrengthen scientific integrity and drive long-term growth.”

About PangeaNatural Foods Inc.

Pangea Natural Foods Inc. is a North Americanmanufacturer specializing in clean-label foods and innovative wellnessproducts. Through its subsidiary Amino Innovations, the Company offersadvanced, non-injectable peptide delivery systems that supportrecovery, cognitive function, and overall health.

On Behalf of the Board ofDirectors

"PratapSandhu"

Pratap Sandhu
CEO, Corporate Secretary and Director

+1 (604) 765-8069
media@pangeafood.com

Forward-Looking Information

This news release containsforward–looking statements and forward–looking information withinthe meaning of applicable securities laws. These statements relate tofuture events or future performance. All statements other thanstatements of historical fact may be forward–looking statements orinformation. The forward–looking statements and information arebased on certain key expectations and assumptions made by themanagement of the Company. As a result, there can be no assurance thatthe acquisition or related matters will be completed as proposed or atall. Although management of the Company believes that the expectationsand assumptions on which such forward-looking statements andinformation are based are reasonable, undue reliance should not beplaced on the forward–looking statements and information since noassurance can be given that they will prove to be correct.

Forward-looking statements andinformation are provided for the purpose of providing informationabout the current expectations and plans of management of the Companyrelating to the future. Readers are cautioned that reliance on suchstatements and information may not be appropriate for other purposes,such as making investment decisions. Since forward–lookingstatements and information address future events and conditions, bytheir very nature they involve inherent risks and uncertainties.Actual results could differ materially from those currentlyanticipated due to a number of factors and risks. These include, butare not limited to, the ability of the Company to complete its plannedfuture activities and anticipated business plans. Other factors mayalso adversely affect the future results or performance of theCompany, including general economic, market or business conditions,changes in the financial markets and changes in laws, regulations andpolicies affecting the Company's operations and theCompany's limited operating history. Accordingly, readers shouldnot place undue reliance on the forward–looking statements and information contained in this newsrelease. Readers are cautioned that the foregoing list of factors isnot exhaustive. The forward– looking statements and informationcontained in this news release are made as of the date hereof and noundertaking is given to update publicly or revise anyforward–looking statements or information, whether as a result ofnew information, future events or otherwise, unless so required byapplicable securities laws. The forward-looking statements orinformation contained in this news release are expressly qualified bythis cautionary statement.

Copyright (c) 2025 TheNewswire - All rights reserved.